
Simon Garaudé
@sgaraude
PhD | Protein Engineering | Gene Editing | Targeted Therapy - Postdoc @Ludwig_Cancer
ID: 1410957991621414914
https://orcid.org/0000-0003-3474-4895 02-07-2021 13:46:31
55 Tweet
99 Followers
360 Following


UNIVERSAL DISEASED HEMATOPOIETIC SYSTEM REPLACEMENT: Antibody–drug conjugate targeting CD45 & transplantation of CD45-targeting refractory HSCs enables the selective eradication of leukemic cells with preserved hematopoiesis nature Simon Garaudé Romina Matter Marone nature.com/articles/s4158…



Imagine this: ... in vivo gene edit of hematopoiesis for a genetic disease ... ... combined with a second edit (see below) ... ... and then safely removing the unedited cells to heal hematopoiesis! No need to imagine - it's right here!! 👏Team Cimeio Therapeutics nature.com/articles/s4158…


Like a mixing console blending not songs but blood systems: Researchers demonstrate how to specifically shut down a #leukemia-affected blood system and simultaneously build a new one. Department of Biomedicine UniSpitalBaselCH unibas.ch/en/News-Events…




💡 New approaches to #BloodCancer: Standard practice relied on treating it by using high doses of #chemotherapy. Today, new approaches create renewed hope, potentially offering treatment options with minimal side effects. Learn about Caribou Biosciences & others: forbes.com/sites/juergene…


🔬 An exciting #hematopoietic cell therapy was developed by University of Basel researchers! They found that a CD45 antibody-drug conjugate eradicated aggressive leukemic cells in vivo by using products such as MethoCult™ and StemSpan™. Cimeio Therapeutics: bit.ly/3S89GJS




